XNAS 15 Oct, 2026 10:51 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Mr. Sudhindra Kankanwadi | Deputy CFO & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.88 per share. | 05 Oct 2026 | 3,000 | 25,717 (0%) | 0% | 135.9 | 407,640 | - |
| Mr. Sudhindra Kankanwadi | Deputy CFO & CAO | Sale of securities on an exchange or to another person at price $ 484.78 per share. | 05 Oct 2026 | 3,000 | 22,717 (0%) | 0% | 484.8 | 1,454,340 | - |
| Mr. Sudhindra Kankanwadi | Deputy CFO & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.88 per share. | 05 Oct 2026 | 9,170 | 31,887 (0%) | 0% | 135.9 | 1,246,020 | - |
| Mr. Sudhindra Kankanwadi | Deputy CFO & CAO | Sale of securities on an exchange or to another person at price $ 500.00 per share. | 05 Oct 2026 | 9,170 | 22,717 (0%) | 0% | 500 | 4,585,000 | - |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.88 per share. | 15 Sep 2026 | 14,604 | 91,469 (0%) | 0% | 135.9 | 1,984,392 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 15 Sep 2026 | 14,604 | 14,604 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 374.88 per share. | 15 Sep 2026 | 14,604 | 76,865 (0%) | 0% | 374.9 | 5,474,683 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 441.76 per share. | 31 Aug 2026 | 25,000 | 120,421 (0%) | 0% | 441.8 | 11,044,115 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Other type of transaction at price $ 360.95 per share. | 31 Aug 2026 | 22 | 120,443 (0%) | 0% | 361.0 | 7,941 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.88 per share. | 31 Aug 2026 | 25,000 | 145,421 (0%) | 0% | 135.9 | 3,397,000 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 31 Aug 2026 | 24,641 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 31 Aug 2026 | 25,000 | 24,641 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 419.44 per share. | 31 Aug 2026 | 24,641 | 120,443 (0%) | 0% | 419.4 | 10,335,424 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.88 per share. | 31 Aug 2026 | 24,641 | 145,084 (0%) | 0% | 135.9 | 3,348,219 | Common Stock |
| Mr. Sudhindra Kankanwadi | Deputy CFO & CAO | Other type of transaction at price $ 360.96 per share. | 31 Aug 2026 | 27 | 22,717 (0%) | 0% | 361.0 | 9,746 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Other type of transaction at price $ 360.96 per share. | 31 Aug 2026 | 27 | 76,865 (0%) | 0% | 361.0 | 9,746 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.88 per share. | 28 Aug 2026 | 25,000 | 145,421 (0%) | 0% | 135.9 | 3,397,000 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 28 Aug 2026 | 25,000 | 49,641 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 445.55 per share. | 28 Aug 2026 | 25,000 | 120,421 (0%) | 0% | 445.6 | 11,138,755 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 15 Jun 2026 | 449 | 2,244 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 449 | 120,577 (0%) | 0% | 0 | Common Stock | |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 454.38 per share. | 15 Jun 2026 | 156 | 120,421 (0%) | 0% | 454.4 | 70,883 | Common Stock |
| Mr. Sudhindra Kankanwadi | Deputy CFO & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 454.38 per share. | 15 Jun 2026 | 249 | 22,690 (0%) | 0% | 454.4 | 113,141 | Common Stock |
| Mr. Sudhindra Kankanwadi | Deputy CFO & CAO | 15 Jun 2026 | 720 | 3,597 | - | - | Restricted Stock Units | ||
| Mr. Sudhindra Kankanwadi | Deputy CFO & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 720 | 22,939 (0%) | 0% | 0 | Common Stock | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 458.96 per share. | 15 Jun 2026 | 14,603 | 75,020 (0%) | 0% | 459.0 | 6,702,222 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.88 per share. | 15 Jun 2026 | 14,603 | 89,623 (0%) | 0% | 135.9 | 1,984,256 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 15 Jun 2026 | 3,310 | 16,546 | - | - | Restricted Stock Units | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 15 Jun 2026 | 14,603 | 29,208 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 454.38 per share. | 15 Jun 2026 | 1,492 | 76,838 (0%) | 0% | 454.4 | 677,935 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 3,310 | 78,330 (0%) | 0% | 0 | Common Stock | |
| Ms. Shelagh Glaser | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 454.38 per share. | 15 Jun 2026 | 436 | 1,452 (0%) | 0% | 454.4 | 198,110 | Common Stock |
| Ms. Shelagh Glaser | CFO | 15 Jun 2026 | 1,259 | 6,295 | - | - | Restricted Stock Units | ||
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 1,259 | 1,888 (0%) | 0% | 0 | Common Stock | |
| Ms. Shelagh Glaser | CFO | Sale of securities on an exchange or to another person at price $ 450.02 per share. | 12 Jun 2026 | 3,394 | 14,358 (0%) | 0% | 450.0 | 1,527,372 | Common Stock |
| Mr. Jesse A. Cohn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2026 | 710 | 710 (0%) | 0% | 0 | Common Stock | |
| Mr. Jesse A. Cohn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2026 | 372 | 1,082 (0%) | 0% | 0 | Common Stock | |
| Mr. Bruce R. Chizen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 453 | 16,162 (0%) | 0% | 0 | Common Stock | |
| Ms. Jeannine P. Sargent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 453 | 2,997 (0%) | 0% | 0 | Common Stock | |
| Mr. John G. Schwarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 453 | 13,240 (0%) | 0% | 0 | Common Stock | |
| Ms. Janice Durbin Chaffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 453 | 15,622 (0%) | 0% | 0 | Common Stock | |
| Ms. Mercedes Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 453 | 453 (0%) | 0% | 0 | Common Stock | |
| Mr. Robert G. Painter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 453 | 2,744 (0%) | 0% | 0 | Common Stock | |
| Mr. Ravi K. Vijayaraghavan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 453 | 3,667 (0%) | 0% | 0 | Common Stock | |
| Mr. Peter A. Shimer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 453 | 1,378 (0%) | 0% | 0 | Common Stock | |
| Ms. Janice Durbin Chaffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 453 | 15,622 (0%) | 0% | 0 | - | |
| Mr. Bruce R. Chizen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 453 | 16,162 (0%) | 0% | 0 | - | |
| Mr. Robert G. Painter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 453 | 2,744 (0%) | 0% | 0 | - | |
| Ms. Mercedes Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 453 | 453 (0%) | 0% | 0 | - | |
| Mr. John G. Schwarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 453 | 13,240 (0%) | 0% | 0 | - | |
| Ms. Jeannine P. Sargent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 453 | 2,997 (0%) | 0% | 0 | - | |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 1,763 | 120,758 (0%) | 0% | 0 | Common Stock | |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 15 Mar 2026 | 1,763 | 1,763 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 412.63 per share. | 15 Mar 2026 | 630 | 120,128 (0%) | 0% | 412.6 | 259,957 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | 15 Mar 2026 | 793 | 793 | - | - | Restricted Stock Units | ||
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 793 | 22,507 (0%) | 0% | 0 | Common Stock | |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 412.63 per share. | 15 Mar 2026 | 288 | 22,219 (0%) | 0% | 412.6 | 118,837 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 412.63 per share. | 15 Mar 2026 | 458 | 75,020 (0%) | 0% | 412.6 | 188,985 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 15 Mar 2026 | 1,322 | 1,322 | - | - | Restricted Stock Units | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 1,322 | 75,478 (0%) | 0% | 0 | Common Stock | |
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 793 | 18,663 (0%) | 0% | 0 | Common Stock | |
| Ms. Shelagh Glaser | CFO | 15 Mar 2026 | 793 | 793 | - | - | Restricted Stock Units | ||
| Ms. Shelagh Glaser | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 412.63 per share. | 15 Mar 2026 | 282 | 18,381 (0%) | 0% | 412.6 | 116,362 | Common Stock |
| Dr. Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 1,763 | 120,758 (0%) | 0% | 0 | - | |
| Dr. Aart J. De Geus | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 412.63 per share. | 15 Mar 2026 | 630 | 120,128 (0%) | 0% | 412.6 | 259,957 | - |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 1,322 | 75,478 (0%) | 0% | 0 | - | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 412.63 per share. | 15 Mar 2026 | 458 | 75,020 (0%) | 0% | 412.6 | 188,985 | - |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 793 | 22,507 (0%) | 0% | 0 | - | |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 412.63 per share. | 15 Mar 2026 | 288 | 22,219 (0%) | 0% | 412.6 | 118,837 | - |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Other type of transaction at price $ 351.89 per share. | 27 Feb 2026 | 28 | 118,995 (0%) | 0% | 351.9 | 9,853 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Other type of transaction at price $ 351.89 per share. | 27 Feb 2026 | 28 | 21,714 (0%) | 0% | 351.9 | 9,853 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Other type of transaction at price $ 351.89 per share. | 27 Feb 2026 | 28 | 74,156 (0%) | 0% | 351.9 | 9,853 | Common Stock |
| Ms. Shelagh Glaser | CFO | Other type of transaction at price $ 351.89 per share. | 27 Feb 2026 | 28 | 17,870 (0%) | 0% | 351.9 | 9,853 | Common Stock |
| Mr. Peter A. Shimer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 845 | 845 (0%) | 0% | 0 | Common Stock | |
| Mr. Peter A. Shimer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 80 | 925 (0%) | 0% | 0 | Common Stock | |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Other type of transaction at price $ 351.89 per share. | 27 Feb 2026 | 28 | 21,714 (0%) | 0% | 351.9 | 9,853 | - |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Other type of transaction at price $ 351.89 per share. | 27 Feb 2026 | 28 | 74,156 (0%) | 0% | 351.9 | 9,853 | - |
| Dr. Aart J. De Geus | Director, EXECUTIVE CHAIR | Other type of transaction at price $ 351.89 per share. | 27 Feb 2026 | 28 | 118,995 (0%) | 0% | 351.9 | 9,853 | - |
| Ms. Shelagh Glaser | CFO | Sale of securities on an exchange or to another person at price $ 460.77 per share. | 19 Dec 2025 | 2,613 | 17,842 (0%) | 0% | 460.8 | 1,203,992 | Common Stock |
| Ms. Shelagh Glaser | CFO | 19 Dec 2025 | 1,044 | 5,365 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Ms. Shelagh Glaser | CFO | 19 Dec 2025 | 2,613 | 10,448 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 354.45 per share. | 19 Dec 2025 | 1,044 | 18,886 (0%) | 0% | 354.5 | 370,046 | Common Stock |
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 348.17 per share. | 19 Dec 2025 | 2,613 | 20,455 (0%) | 0% | 348.2 | 909,768 | Common Stock |
| Ms. Shelagh Glaser | CFO | Sale of securities on an exchange or to another person at price $ 460.77 per share. | 19 Dec 2025 | 1,044 | 17,842 (0%) | 0% | 460.8 | 481,044 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 16 Dec 2025 | 2,693 | 2,693 | - | - | Restricted Stock Units | ||
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | 16 Dec 2025 | 4,317 | 4,317 | - | - | Restricted Stock Units | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 16 Dec 2025 | 19,856 | 19,856 | - | - | Restricted Stock Units | ||
| Ms. Shelagh Glaser | CFO | 16 Dec 2025 | 7,554 | 7,554 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 1,234 | 118,820 (0%) | 0% | 0 | Common Stock | |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 08 Dec 2025 | 626 | 1,877 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 08 Dec 2025 | 882 | 1,763 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 08 Dec 2025 | 1,234 | 0 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 311 | 118,967 (0%) | 0% | 465.7 | 144,848 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 626 | 119,278 (0%) | 0% | 0 | Common Stock | |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 438 | 118,652 (0%) | 0% | 465.8 | 203,999 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 882 | 119,090 (0%) | 0% | 0 | Common Stock | |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 612 | 118,208 (0%) | 0% | 465.8 | 285,039 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | 08 Dec 2025 | 562 | 4,158 | - | - | Restricted Stock Units | ||
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | 08 Dec 2025 | 740 | 0 | - | - | Restricted Stock Units | ||
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 502 | 21,686 (0%) | 0% | 465.8 | 233,807 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 1,012 | 22,188 (0%) | 0% | 0 | Common Stock | |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 279 | 21,176 (0%) | 0% | 465.7 | 129,944 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 562 | 21,455 (0%) | 0% | 0 | Common Stock | |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 367 | 20,893 (0%) | 0% | 465.7 | 170,930 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 740 | 21,260 (0%) | 0% | 0 | Common Stock | |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | 08 Dec 2025 | 1,012 | 3,146 | - | - | Restricted Stock Units | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 08 Dec 2025 | 1,654 | 3,306 | - | - | Restricted Stock Units | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 08 Dec 2025 | 1,058 | 0 | - | - | Restricted Stock Units | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 1,129 | 74,128 (0%) | 0% | 465.8 | 525,832 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 2,276 | 75,257 (0%) | 0% | 0 | Common Stock | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 821 | 72,981 (0%) | 0% | 465.8 | 382,381 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 1,654 | 73,802 (0%) | 0% | 0 | Common Stock | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 525 | 72,148 (0%) | 0% | 465.8 | 244,519 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 1,058 | 72,673 (0%) | 0% | 0 | Common Stock | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 08 Dec 2025 | 2,276 | 6,826 | - | - | Restricted Stock Units | ||
| Ms. Shelagh Glaser | CFO | 08 Dec 2025 | 759 | 2,275 | - | - | Restricted Stock Units | ||
| Ms. Shelagh Glaser | CFO | 08 Dec 2025 | 3,590 | 3,590 | - | - | Restricted Stock Units | ||
| Ms. Shelagh Glaser | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 377 | 17,842 (0%) | 0% | 465.8 | 175,588 | Common Stock |
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 759 | 18,219 (0%) | 0% | 0 | Common Stock | |
| Ms. Shelagh Glaser | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 329 | 17,460 (0%) | 0% | 465.8 | 153,232 | Common Stock |
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 662 | 17,789 (0%) | 0% | 0 | Common Stock | |
| Ms. Shelagh Glaser | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 1,780 | 17,127 (0%) | 0% | 465.8 | 829,035 | Common Stock |
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 3,590 | 18,907 (0%) | 0% | 0 | Common Stock | |
| Ms. Shelagh Glaser | CFO | 08 Dec 2025 | 662 | 1,322 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 1,234 | 118,820 (0%) | 0% | 0 | - | |
| Dr. Aart J. De Geus | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 612 | 118,208 (0%) | 0% | 465.8 | 285,039 | - |
| Dr. Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 882 | 119,090 (0%) | 0% | 0 | - | |
| Dr. Aart J. De Geus | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 438 | 118,652 (0%) | 0% | 465.8 | 203,999 | - |
| Dr. Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 626 | 119,278 (0%) | 0% | 0 | - | |
| Dr. Aart J. De Geus | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 311 | 118,967 (0%) | 0% | 465.7 | 144,848 | - |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 740 | 21,260 (0%) | 0% | 0 | - | |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 367 | 20,893 (0%) | 0% | 465.7 | 170,930 | - |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 562 | 21,455 (0%) | 0% | 0 | - | |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 279 | 21,176 (0%) | 0% | 465.7 | 129,944 | - |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 1,012 | 22,188 (0%) | 0% | 0 | - | |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 502 | 21,686 (0%) | 0% | 465.8 | 233,807 | - |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 1,058 | 72,673 (0%) | 0% | 0 | - | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 525 | 72,148 (0%) | 0% | 465.8 | 244,519 | - |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 1,654 | 73,802 (0%) | 0% | 0 | - | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 821 | 72,981 (0%) | 0% | 465.8 | 382,381 | - |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 2,276 | 75,257 (0%) | 0% | 0 | - | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.75 per share. | 08 Dec 2025 | 1,129 | 74,128 (0%) | 0% | 465.8 | 525,832 | - |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 19 Sep 2025 | 6,000 | 26,520 (0%) | 0% | 89.8 | 538,560 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | 19 Sep 2025 | 6,000 | 9,873 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | 19 Sep 2025 | 9,873 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 500.90 per share. | 19 Sep 2025 | 9,873 | 20,520 (0%) | 0% | 500.9 | 4,945,408 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 19 Sep 2025 | 9,873 | 30,393 (0%) | 0% | 89.8 | 886,200 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 482.00 per share. | 19 Sep 2025 | 6,000 | 20,520 (0%) | 0% | 482 | 2,892,000 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 19 Sep 2025 | 6,000 | 26,520 (0%) | 0% | 89.8 | 538,560 | - |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 482.00 per share. | 19 Sep 2025 | 6,000 | 20,520 (0%) | 0% | 482 | 2,892,000 | - |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 19 Sep 2025 | 9,873 | 30,393 (0%) | 0% | 89.8 | 886,200 | - |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 500.90 per share. | 19 Sep 2025 | 9,873 | 20,520 (0%) | 0% | 500.9 | 4,945,408 | - |
| Dr. Ajei S. Gopal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 342 | 166,948 (0%) | 0% | 0 | Common Stock | |
| Dr. Ajei S. Gopal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 798 | 167,746 (0%) | 0% | 0 | Common Stock | |
| Mr. Ravi K. Vijayaraghavan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 798 | 3,214 (0%) | 0% | 0 | Common Stock | |
| Mr. Ravi K. Vijayaraghavan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 342 | 2,416 (0%) | 0% | 0 | Common Stock | |
| Mr. Robert G. Painter | Director | Purchase of securities on an exchange or from another person at price $ 425.44 per share. | 11 Sep 2025 | 350 | 2,291 (0%) | 0% | 425.4 | 148,904 | Common Stock |
| Mr. Robert G. Painter | Director | Purchase of securities on an exchange or from another person at price $ 425.44 per share. | 11 Sep 2025 | 350 | 2,291 (0%) | 0% | 425.4 | 148,904 | - |
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 348.17 per share. | 05 Sep 2025 | 2,612 | 17,929 (0%) | 0% | 348.2 | 909,420 | Common Stock |
| Ms. Shelagh Glaser | CFO | 05 Sep 2025 | 2,612 | 13,061 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Ms. Shelagh Glaser | CFO | 05 Sep 2025 | 1,043 | 6,409 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Ms. Shelagh Glaser | CFO | Sale of securities on an exchange or to another person at price $ 609.77 per share. | 05 Sep 2025 | 1,043 | 15,317 (0%) | 0% | 609.8 | 635,990 | Common Stock |
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 354.45 per share. | 05 Sep 2025 | 1,043 | 16,360 (0%) | 0% | 354.4 | 369,691 | Common Stock |
| Ms. Shelagh Glaser | CFO | Sale of securities on an exchange or to another person at price $ 609.77 per share. | 05 Sep 2025 | 2,612 | 15,317 (0%) | 0% | 609.8 | 1,592,719 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 02 Sep 2025 | 11,366 | 82,981 (0%) | 0% | 89.8 | 1,020,212 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 02 Sep 2025 | 11,366 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 589.01 per share. | 02 Sep 2025 | 11,366 | 71,615 (0%) | 0% | 589.0 | 6,694,725 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Other type of transaction at price $ 376.77 per share. | 02 Sep 2025 | 26 | 71,615 (0%) | 0% | 376.8 | 9,796 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Other type of transaction at price $ 376.77 per share. | 02 Sep 2025 | 26 | 71,615 (0%) | 0% | 376.8 | 9,796 | - |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 02 Sep 2025 | 11,366 | 82,981 (0%) | 0% | 89.8 | 1,020,212 | - |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 589.01 per share. | 02 Sep 2025 | 11,366 | 71,615 (0%) | 0% | 589.0 | 6,694,725 | - |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Other type of transaction at price $ 376.77 per share. | 29 Aug 2025 | 26 | 117,586 (0%) | 0% | 376.8 | 9,796 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Other type of transaction at price $ 376.77 per share. | 29 Aug 2025 | 26 | 20,520 (0%) | 0% | 376.8 | 9,796 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Other type of transaction at price $ 376.77 per share. | 29 Aug 2025 | 26 | 1,511 (0%) | 0% | 376.8 | 9,796 | Common Stock |
| Ms. Shelagh Glaser | CFO | Other type of transaction at price $ 376.77 per share. | 29 Aug 2025 | 26 | 15,317 (0%) | 0% | 376.8 | 9,796 | Common Stock |
| Dr. Aart J. De Geus | Director, EXECUTIVE CHAIR | Other type of transaction at price $ 376.77 per share. | 29 Aug 2025 | 26 | 117,586 (0%) | 0% | 376.8 | 9,796 | - |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Other type of transaction at price $ 376.77 per share. | 29 Aug 2025 | 26 | 20,520 (0%) | 0% | 376.8 | 9,796 | - |
| Dr. Ajei S. Gopal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2025 | 6,009 | 101,512 (0%) | 0% | 0 | Common Stock | |
| Dr. Ajei S. Gopal | Director | 31 Jul 2025 | 46,596 | 0 | - | - | Restricted Stock Units | ||
| Dr. Ajei S. Gopal | Director | 31 Jul 2025 | 27,795 | 0 | - | - | Restricted Stock Units | ||
| Dr. Ajei S. Gopal | Director | 31 Jul 2025 | 6,009 | 0 | - | - | Restricted Stock Units | ||
| Dr. Ajei S. Gopal | Director | 31 Jul 2025 | 36,856 | 0 | - | - | Restricted Stock Units | ||
| Dr. Ajei S. Gopal | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 633.47 per share. | 31 Jul 2025 | 14,505 | 166,606 (0%) | 0% | 633.5 | 9,188,482 | Common Stock |
| Dr. Ajei S. Gopal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2025 | 36,856 | 181,111 (0%) | 0% | 0 | Common Stock | |
| Dr. Ajei S. Gopal | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 633.47 per share. | 31 Jul 2025 | 18,339 | 144,255 (0%) | 0% | 633.5 | 11,617,206 | Common Stock |
| Dr. Ajei S. Gopal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2025 | 46,596 | 162,594 (0%) | 0% | 0 | Common Stock | |
| Dr. Ajei S. Gopal | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 633.47 per share. | 31 Jul 2025 | 10,942 | 115,998 (0%) | 0% | 633.5 | 6,931,429 | Common Stock |
| Dr. Ajei S. Gopal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2025 | 27,795 | 126,940 (0%) | 0% | 0 | Common Stock | |
| Dr. Ajei S. Gopal | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 633.47 per share. | 31 Jul 2025 | 2,367 | 99,145 (0%) | 0% | 633.5 | 1,499,423 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 471.19 per share. | 18 Jun 2025 | 4,869 | 1,485 (0%) | 0% | 471.2 | 2,294,220 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 354.45 per share. | 18 Jun 2025 | 1,192 | 2,677 (0%) | 0% | 354.4 | 422,504 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 471.18 per share. | 18 Jun 2025 | 1,192 | 1,485 (0%) | 0% | 471.2 | 561,642 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | 18 Jun 2025 | 1,192 | 4,173 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Richard S. Mahoney | Chief Revenue Officer | 18 Jun 2025 | 2,949 | 5,898 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Richard S. Mahoney | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 471.27 per share. | 18 Jun 2025 | 2,949 | 1,485 (0%) | 0% | 471.3 | 1,389,783 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 319.20 per share. | 18 Jun 2025 | 2,949 | 4,434 (0%) | 0% | 319.2 | 941,321 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 7,832 | 9,765 (0%) | 0% | 0 | Common Stock | |
| Mr. Richard S. Mahoney | Chief Revenue Officer | 15 Jun 2025 | 7,832 | 7,832 | - | - | Restricted Stock Units | ||
| Mr. Richard S. Mahoney | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.86 per share. | 15 Jun 2025 | 3,411 | 6,354 (0%) | 0% | 478.9 | 1,633,391 | Common Stock |
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 354.45 per share. | 06 Jun 2025 | 2,086 | 17,377 (0%) | 0% | 354.5 | 739,383 | Common Stock |
| Ms. Shelagh Glaser | CFO | 06 Jun 2025 | 2,086 | 7,452 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Ms. Shelagh Glaser | CFO | 06 Jun 2025 | 5,224 | 15,673 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Ms. Shelagh Glaser | CFO | Sale of securities on an exchange or to another person at price $ 485.72 per share. | 06 Jun 2025 | 5,224 | 15,291 (0%) | 0% | 485.7 | 2,537,398 | Common Stock |
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 348.17 per share. | 06 Jun 2025 | 5,224 | 20,515 (0%) | 0% | 348.2 | 1,818,840 | Common Stock |
| Ms. Shelagh Glaser | CFO | Sale of securities on an exchange or to another person at price $ 485.72 per share. | 06 Jun 2025 | 2,086 | 15,291 (0%) | 0% | 485.7 | 1,013,211 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 02 Jun 2025 | 11,366 | 11,366 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 457.93 per share. | 02 Jun 2025 | 11,366 | 71,589 (0%) | 0% | 457.9 | 5,204,786 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 02 Jun 2025 | 11,366 | 82,955 (0%) | 0% | 89.8 | 1,020,212 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 02 Jun 2025 | 11,366 | 82,955 (0%) | 0% | 89.8 | 1,020,212 | - |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 457.93 per share. | 02 Jun 2025 | 11,366 | 71,589 (0%) | 0% | 457.9 | 5,204,786 | - |
| Mr. Bruce R. Chizen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 491 | 15,709 (0%) | 0% | 0 | Common Stock | |
| Ms. Jeannine P. Sargent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 491 | 2,544 (0%) | 0% | 0 | Common Stock | |
| Mr. John G. Schwarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 491 | 12,787 (0%) | 0% | 0 | Common Stock | |
| Ms. Janice Durbin Chaffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 491 | 15,169 (0%) | 0% | 0 | Common Stock | |
| Ms. Mercedes Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 491 | 491 (0%) | 0% | 0 | Common Stock | |
| Mr. Luis A. Borgen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 491 | 1,833 (0%) | 0% | 0 | Common Stock | |
| Mr. Robert G. Painter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 491 | 1,941 (0%) | 0% | 0 | Common Stock | |
| Mr. Luis A. Borgen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 491 | 1,833 (0%) | 0% | 0 | - | |
| Ms. Mercedes Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 491 | 491 (0%) | 0% | 0 | - | |
| Mr. Bruce R. Chizen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 491 | 15,709 (0%) | 0% | 0 | - | |
| Ms. Janice Durbin Chaffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 491 | 15,169 (0%) | 0% | 0 | - | |
| Mr. Robert G. Painter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 491 | 1,941 (0%) | 0% | 0 | - | |
| Mr. John G. Schwarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 491 | 12,787 (0%) | 0% | 0 | - | |
| Ms. Jeannine P. Sargent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 491 | 2,544 (0%) | 0% | 0 | - | |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.23 per share. | 15 Mar 2025 | 151 | 23,383 (0%) | 0% | 446.2 | 67,381 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 406 | 23,534 (0%) | 0% | 0 | Common Stock | |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 15 Mar 2025 | 406 | 811 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,764 | 118,435 (0%) | 0% | 0 | Common Stock | |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.23 per share. | 15 Mar 2025 | 875 | 117,560 (0%) | 0% | 446.2 | 390,451 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 15 Mar 2025 | 1,764 | 3,526 | - | - | Restricted Stock Units | ||
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | 15 Mar 2025 | 794 | 1,586 | - | - | Restricted Stock Units | ||
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.23 per share. | 15 Mar 2025 | 286 | 20,494 (0%) | 0% | 446.2 | 127,622 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 794 | 20,780 (0%) | 0% | 0 | Common Stock | |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.23 per share. | 15 Mar 2025 | 346 | 1,933 (0%) | 0% | 446.2 | 154,396 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 794 | 2,279 (0%) | 0% | 0 | Common Stock | |
| Mr. Richard S. Mahoney | Chief Revenue Officer | 15 Mar 2025 | 794 | 1,586 | - | - | Restricted Stock Units | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.23 per share. | 15 Mar 2025 | 656 | 71,589 (0%) | 0% | 446.2 | 292,727 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,323 | 72,245 (0%) | 0% | 0 | Common Stock | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 15 Mar 2025 | 1,323 | 2,644 | - | - | Restricted Stock Units | ||
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 794 | 15,572 (0%) | 0% | 0 | Common Stock | |
| Ms. Shelagh Glaser | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.23 per share. | 15 Mar 2025 | 281 | 15,291 (0%) | 0% | 446.2 | 125,391 | Common Stock |
| Ms. Shelagh Glaser | CFO | 15 Mar 2025 | 794 | 1,586 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,764 | 118,435 (0%) | 0% | 0 | - | |
| Dr. Aart J. De Geus | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.23 per share. | 15 Mar 2025 | 875 | 117,560 (0%) | 0% | 446.2 | 390,451 | - |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,323 | 72,245 (0%) | 0% | 0 | - | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.23 per share. | 15 Mar 2025 | 656 | 71,589 (0%) | 0% | 446.2 | 292,727 | - |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 794 | 20,780 (0%) | 0% | 0 | - | |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.23 per share. | 15 Mar 2025 | 286 | 20,494 (0%) | 0% | 446.2 | 127,622 | - |
| Mr. John F. Runkel | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 406 | 23,534 (0%) | 0% | 0 | - | |
| Mr. John F. Runkel | GC & Corporate Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.23 per share. | 15 Mar 2025 | 151 | 23,383 (0%) | 0% | 446.2 | 67,381 | - |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 06 Mar 2025 | 15,705 | 132,376 (0%) | 0% | 89.8 | 1,409,681 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 06 Mar 2025 | 15,705 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 444.42 per share. | 06 Mar 2025 | 15,705 | 116,671 (0%) | 0% | 444.4 | 6,979,652 | Common Stock |
| Dr. Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 06 Mar 2025 | 15,705 | 132,376 (0%) | 0% | 89.8 | 1,409,681 | - |
| Dr. Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 444.42 per share. | 06 Mar 2025 | 15,705 | 116,671 (0%) | 0% | 444.4 | 6,979,652 | - |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 463.75 per share. | 03 Mar 2025 | 11,366 | 70,922 (0%) | 0% | 463.7 | 5,270,969 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Other type of transaction at price $ 388.68 per share. | 03 Mar 2025 | 25 | 70,922 (0%) | 0% | 388.7 | 9,717 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 03 Mar 2025 | 11,366 | 82,288 (0%) | 0% | 89.8 | 1,020,212 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 03 Mar 2025 | 11,366 | 22,732 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Other type of transaction at price $ 388.68 per share. | 03 Mar 2025 | 25 | 70,922 (0%) | 0% | 388.7 | 9,717 | - |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 03 Mar 2025 | 11,366 | 82,288 (0%) | 0% | 89.8 | 1,020,212 | - |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 463.75 per share. | 03 Mar 2025 | 11,366 | 70,922 (0%) | 0% | 463.7 | 5,270,969 | - |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Other type of transaction at price $ 388.68 per share. | 28 Feb 2025 | 25 | 23,128 (0%) | 0% | 388.7 | 9,717 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Other type of transaction at price $ 388.68 per share. | 28 Feb 2025 | 25 | 116,671 (0%) | 0% | 388.7 | 9,717 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Other type of transaction at price $ 388.68 per share. | 28 Feb 2025 | 25 | 19,986 (0%) | 0% | 388.7 | 9,717 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Other type of transaction at price $ 388.68 per share. | 28 Feb 2025 | 25 | 1,485 (0%) | 0% | 388.7 | 9,717 | Common Stock |
| Ms. Shelagh Glaser | CFO | Other type of transaction at price $ 306.88 per share. | 28 Feb 2025 | 32 | 14,778 (0%) | 0% | 306.9 | 9,820 | Common Stock |
| Dr. Aart J. De Geus | Director, EXECUTIVE CHAIR | Other type of transaction at price $ 388.68 per share. | 28 Feb 2025 | 25 | 116,671 (0%) | 0% | 388.7 | 9,717 | - |
| Mr. John F. Runkel | GC & Corporate Secretary | Other type of transaction at price $ 388.68 per share. | 28 Feb 2025 | 25 | 23,128 (0%) | 0% | 388.7 | 9,717 | - |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Other type of transaction at price $ 388.68 per share. | 28 Feb 2025 | 25 | 19,986 (0%) | 0% | 388.7 | 9,717 | - |
| Mr. Richard S. Mahoney | Chief Revenue Officer | 15 Jan 2025 | 4,173 | 5,365 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Richard S. Mahoney | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 506.07 per share. | 15 Jan 2025 | 6,343 | 1,460 (0%) | 0% | 506.1 | 3,210,008 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | 15 Jan 2025 | 10,322 | 8,847 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Richard S. Mahoney | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 319.20 per share. | 15 Jan 2025 | 10,322 | 18,125 (0%) | 0% | 319.2 | 3,294,782 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 505.99 per share. | 15 Jan 2025 | 10,322 | 7,803 (0%) | 0% | 506.0 | 5,222,796 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 354.45 per share. | 15 Jan 2025 | 4,173 | 11,976 (0%) | 0% | 354.5 | 1,479,120 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 505.97 per share. | 15 Jan 2025 | 4,173 | 7,803 (0%) | 0% | 506.0 | 2,111,401 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jan 2025 | 40 | 23,103 (0%) | 0% | 0 | Common Stock | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jan 2025 | 450 | 70,897 (0%) | 0% | 0 | Common Stock | |
| Mr. John F. Runkel | GC & Corporate Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jan 2025 | 40 | 23,103 (0%) | 0% | 0 | - | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jan 2025 | 450 | 70,897 (0%) | 0% | 0 | - | |
| Ms. Shelagh Glaser | CFO | 18 Dec 2024 | 3,034 | 3,034 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 18 Dec 2024 | 7,323 | 7,323 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 18 Dec 2024 | 9,102 | 9,102 | - | - | Restricted Stock Units | ||
| Mr. Richard S. Mahoney | Chief Revenue Officer | 18 Dec 2024 | 2,529 | 2,529 | - | - | Restricted Stock Units | ||
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | 18 Dec 2024 | 2,959 | 2,959 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 18 Dec 2024 | 26,628 | 26,628 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 18 Dec 2024 | 3,403 | 3,403 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 18 Dec 2024 | 1,163 | 1,163 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 18 Dec 2024 | 2,503 | 2,503 | - | - | Restricted Stock Units | ||
| Mr. Richard S. Mahoney | Chief Revenue Officer | 18 Dec 2024 | 7,397 | 7,397 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | 18 Dec 2024 | 3,034 | 4,720 | - | - | Restricted Stock Units | ||
| Ms. Shelagh Glaser | CFO | 18 Dec 2024 | 8,876 | 8,876 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 126 | 23,143 (0%) | 0% | 517.3 | 65,177 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 254 | 23,269 (0%) | 0% | 0 | Common Stock | |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 202 | 23,015 (0%) | 0% | 517.3 | 104,491 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 406 | 23,217 (0%) | 0% | 0 | Common Stock | |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 292 | 22,811 (0%) | 0% | 517.3 | 151,046 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 587 | 23,103 (0%) | 0% | 0 | Common Stock | |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 1,859 | 22,516 (0%) | 0% | 517.3 | 961,624 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 3,749 | 24,375 (0%) | 0% | 0 | Common Stock | |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 583 | 20,626 (0%) | 0% | 517.3 | 301,574 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,174 | 21,209 (0%) | 0% | 0 | Common Stock | |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 06 Dec 2024 | 1,174 | 587 | - | - | Restricted Stock Units | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 06 Dec 2024 | 587 | 0 | - | - | Restricted Stock Units | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 06 Dec 2024 | 406 | 405 | - | - | Restricted Stock Units | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 06 Dec 2024 | 254 | 761 | - | - | Restricted Stock Units | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 06 Dec 2024 | 3,749 | 0 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,868 | 116,507 (0%) | 0% | 0 | Common Stock | |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 06 Dec 2024 | 11,408 | 0 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 06 Dec 2024 | 882 | 2,645 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 06 Dec 2024 | 1,234 | 1,234 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 06 Dec 2024 | 1,868 | 0 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 06 Dec 2024 | 3,736 | 1,868 | - | - | Restricted Stock Units | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 438 | 116,646 (0%) | 0% | 517.3 | 226,569 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 882 | 117,084 (0%) | 0% | 0 | Common Stock | |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 612 | 116,202 (0%) | 0% | 517.3 | 316,575 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,234 | 116,814 (0%) | 0% | 0 | Common Stock | |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 927 | 115,580 (0%) | 0% | 517.3 | 479,519 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 5,657 | 114,639 (0%) | 0% | 517.3 | 2,926,253 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 11,408 | 120,296 (0%) | 0% | 0 | Common Stock | |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 1,853 | 108,888 (0%) | 0% | 517.3 | 958,520 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 3,736 | 110,741 (0%) | 0% | 0 | Common Stock | |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 352 | 19,305 (0%) | 0% | 517.3 | 182,083 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 741 | 20,046 (0%) | 0% | 0 | Common Stock | |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 881 | 19,657 (0%) | 0% | 0 | Common Stock | |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 368 | 19,678 (0%) | 0% | 517.3 | 190,359 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 563 | 20,241 (0%) | 0% | 0 | Common Stock | |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 280 | 19,961 (0%) | 0% | 517.3 | 144,838 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | 06 Dec 2024 | 881 | 0 | - | - | Restricted Stock Units | ||
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | 06 Dec 2024 | 741 | 740 | - | - | Restricted Stock Units | ||
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | 06 Dec 2024 | 563 | 1,686 | - | - | Restricted Stock Units | ||
| Mr. Richard S. Mahoney | Chief Revenue Officer | 06 Dec 2024 | 658 | 1,974 | - | - | Restricted Stock Units | ||
| Mr. Richard S. Mahoney | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 658 | 3,945 (0%) | 0% | 0 | Common Stock | |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 287 | 3,658 (0%) | 0% | 517.3 | 148,459 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 7,343 | 11,001 (0%) | 0% | 0 | Common Stock | |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 3,198 | 7,803 (0%) | 0% | 517.3 | 1,654,261 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | 06 Dec 2024 | 7,343 | 0 | - | - | Restricted Stock Units | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 1,324 | 64,379 (0%) | 0% | 517.3 | 684,879 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 06 Dec 2024 | 9,779 | 0 | - | - | Restricted Stock Units | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 06 Dec 2024 | 1,654 | 4,960 | - | - | Restricted Stock Units | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 06 Dec 2024 | 1,058 | 1,058 | - | - | Restricted Stock Units | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 06 Dec 2024 | 1,334 | 0 | - | - | Restricted Stock Units | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 06 Dec 2024 | 2,669 | 1,334 | - | - | Restricted Stock Units | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 821 | 71,347 (0%) | 0% | 517.3 | 424,687 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,654 | 72,168 (0%) | 0% | 0 | Common Stock | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 525 | 70,514 (0%) | 0% | 517.3 | 271,572 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,058 | 71,039 (0%) | 0% | 0 | Common Stock | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 662 | 69,981 (0%) | 0% | 517.3 | 342,439 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,334 | 70,643 (0%) | 0% | 0 | Common Stock | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 4,849 | 69,309 (0%) | 0% | 517.3 | 2,508,291 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 9,779 | 74,158 (0%) | 0% | 0 | Common Stock | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 2,669 | 65,703 (0%) | 0% | 0 | Common Stock | |
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 6,732 | 15,780 (0%) | 0% | 0 | Common Stock | |
| Ms. Shelagh Glaser | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 3,338 | 12,442 (0%) | 0% | 517.3 | 1,726,681 | Common Stock |
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 3,590 | 16,032 (0%) | 0% | 0 | Common Stock | |
| Ms. Shelagh Glaser | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 1,619 | 14,413 (0%) | 0% | 517.3 | 837,476 | Common Stock |
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 662 | 15,075 (0%) | 0% | 0 | Common Stock | |
| Ms. Shelagh Glaser | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 329 | 14,746 (0%) | 0% | 517.3 | 170,185 | Common Stock |
| Ms. Shelagh Glaser | CFO | 06 Dec 2024 | 3,590 | 7,180 | - | - | Restricted Stock Units | ||
| Ms. Shelagh Glaser | CFO | 06 Dec 2024 | 662 | 1,984 | - | - | Restricted Stock Units | ||
| Ms. Shelagh Glaser | CFO | 06 Dec 2024 | 6,732 | 0 | - | - | Restricted Stock Units | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 882 | 63,472 (0%) | 0% | 0 | Common Stock | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 490.07 per share. | 13 Sep 2024 | 438 | 63,034 (0%) | 0% | 490.1 | 214,651 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 13 Sep 2024 | 882 | 0 | - | - | Restricted Stock Units | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Other type of transaction at price $ 282.63 per share. | 30 Aug 2024 | 35 | 20,035 (0%) | 0% | 282.6 | 9,892 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Other type of transaction at price $ 441.64 per share. | 30 Aug 2024 | 22 | 107,005 (0%) | 0% | 441.6 | 9,716 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Other type of transaction at price $ 282.63 per share. | 30 Aug 2024 | 35 | 18,776 (0%) | 0% | 282.6 | 9,892 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Other type of transaction at price $ 441.64 per share. | 30 Aug 2024 | 22 | 3,287 (0%) | 0% | 441.6 | 9,716 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Other type of transaction at price $ 441.64 per share. | 30 Aug 2024 | 22 | 62,590 (0%) | 0% | 441.6 | 9,716 | Common Stock |
| Ms. Shelagh Glaser | CFO | Other type of transaction at price $ 306.88 per share. | 30 Aug 2024 | 32 | 9,048 (0%) | 0% | 306.9 | 9,820 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 90.51 per share. | 23 Aug 2024 | 10,293 | 72,861 (0%) | 0% | 90.5 | 931,619 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 23 Aug 2024 | 10,293 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 553.89 per share. | 23 Aug 2024 | 10,293 | 62,568 (0%) | 0% | 553.9 | 5,701,201 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jul 2024 | 186,551 | 0 (0%) | 0% | 0 | Common Stock | |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 620.60 per share. | 15 Jul 2024 | 493 | 106,983 (0%) | 0% | 620.6 | 305,954 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 15 Jul 2024 | 493 | 107,476 (0%) | 0% | 89.8 | 44,252 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 15 Jul 2024 | 493 | 15,705 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 10 Jul 2024 | 8,648 | 115,631 (0%) | 0% | 89.8 | 776,244 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 10 Jul 2024 | 4,588 | 16,198 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 10 Jul 2024 | 8,648 | 20,786 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 621.68 per share. | 10 Jul 2024 | 4,588 | 106,983 (0%) | 0% | 621.7 | 2,852,273 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 10 Jul 2024 | 4,588 | 111,571 (0%) | 0% | 89.8 | 411,819 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 620.29 per share. | 10 Jul 2024 | 8,648 | 106,983 (0%) | 0% | 620.3 | 5,364,265 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 05 Jul 2024 | 27,753 | 134,736 (0%) | 0% | 89.8 | 2,491,109 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 05 Jul 2024 | 27,753 | 34,882 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 05 Jul 2024 | 5,448 | 29,434 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 620.95 per share. | 05 Jul 2024 | 5,448 | 106,983 (0%) | 0% | 620.9 | 3,382,929 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 05 Jul 2024 | 5,448 | 112,431 (0%) | 0% | 89.8 | 489,012 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 618.58 per share. | 05 Jul 2024 | 27,753 | 106,983 (0%) | 0% | 618.6 | 17,167,470 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 02 Jul 2024 | 4,340 | 111,323 (0%) | 0% | 89.8 | 389,558 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 02 Jul 2024 | 2,789 | 62,635 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 02 Jul 2024 | 4,340 | 65,424 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 610.94 per share. | 02 Jul 2024 | 2,789 | 106,983 (0%) | 0% | 610.9 | 1,703,912 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 02 Jul 2024 | 2,789 | 109,772 (0%) | 0% | 89.8 | 250,341 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 610.25 per share. | 02 Jul 2024 | 4,340 | 106,983 (0%) | 0% | 610.3 | 2,648,498 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 28 Jun 2024 | 11,185 | 118,168 (0%) | 0% | 89.8 | 1,003,966 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 28 Jun 2024 | 5,893 | 69,764 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 28 Jun 2024 | 11,185 | 75,657 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 602.00 per share. | 28 Jun 2024 | 5,893 | 106,983 (0%) | 0% | 602.0 | 3,547,564 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 28 Jun 2024 | 5,893 | 112,876 (0%) | 0% | 89.8 | 528,956 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 603.94 per share. | 28 Jun 2024 | 11,185 | 106,983 (0%) | 0% | 603.9 | 6,755,057 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 602.59 per share. | 26 Jun 2024 | 8,158 | 106,983 (0%) | 0% | 602.6 | 4,915,913 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 26 Jun 2024 | 8,158 | 115,141 (0%) | 0% | 89.8 | 732,262 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 600.57 per share. | 26 Jun 2024 | 2,899 | 106,983 (0%) | 0% | 600.6 | 1,741,062 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 26 Jun 2024 | 2,899 | 109,882 (0%) | 0% | 89.8 | 260,214 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 26 Jun 2024 | 8,158 | 86,842 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 26 Jun 2024 | 2,899 | 95,000 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 24 Jun 2024 | 2,535 | 109,518 (0%) | 0% | 89.8 | 227,542 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 24 Jun 2024 | 2,535 | 102,111 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 24 Jun 2024 | 4,212 | 97,899 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 600.05 per share. | 24 Jun 2024 | 4,212 | 106,983 (0%) | 0% | 600.1 | 2,527,414 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 24 Jun 2024 | 4,212 | 111,195 (0%) | 0% | 89.8 | 378,069 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 600.99 per share. | 24 Jun 2024 | 2,535 | 106,983 (0%) | 0% | 601.0 | 1,523,498 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 611.41 per share. | 18 Jun 2024 | 3,316 | 3,265 (0%) | 0% | 611.4 | 2,027,436 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 7,832 | 9,992 (0%) | 0% | 0 | Common Stock | |
| Mr. Richard S. Mahoney | Chief Revenue Officer | 15 Jun 2024 | 7,832 | 15,664 | - | - | Restricted Stock Units | ||
| Mr. Richard S. Mahoney | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 590.21 per share. | 15 Jun 2024 | 3,411 | 6,581 (0%) | 0% | 590.2 | 2,013,206 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 354.48 per share. | 10 Jun 2024 | 366 | 20,366 (0%) | 0% | 354.5 | 129,740 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 10 Jun 2024 | 366 | 2,197 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 10 Jun 2024 | 570 | 1,139 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Sale of securities on an exchange or to another person at price $ 566.97 per share. | 10 Jun 2024 | 570 | 20,000 (0%) | 0% | 567.0 | 323,173 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 234.17 per share. | 10 Jun 2024 | 570 | 20,570 (0%) | 0% | 234.2 | 133,477 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Sale of securities on an exchange or to another person at price $ 566.97 per share. | 10 Jun 2024 | 366 | 20,000 (0%) | 0% | 567.0 | 207,511 | Common Stock |
| Ms. Mercedes Johnson | Director | Sale of securities on an exchange or to another person at price $ 581.38 per share. | 28 May 2024 | 5,500 | 1,543 (0%) | 0% | 581.4 | 3,197,590 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Sale of securities on an exchange or to another person at price $ 582.90 per share. | 24 May 2024 | 569 | 20,000 (0%) | 0% | 582.9 | 331,670 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 24 May 2024 | 366 | 2,563 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 24 May 2024 | 304 | 3,352 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 24 May 2024 | 569 | 1,709 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 234.17 per share. | 24 May 2024 | 569 | 20,569 (0%) | 0% | 234.2 | 133,243 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Sale of securities on an exchange or to another person at price $ 582.90 per share. | 24 May 2024 | 366 | 20,000 (0%) | 0% | 582.9 | 213,341 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 354.48 per share. | 24 May 2024 | 366 | 20,366 (0%) | 0% | 354.5 | 129,740 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Sale of securities on an exchange or to another person at price $ 582.90 per share. | 24 May 2024 | 304 | 20,000 (0%) | 0% | 582.9 | 177,202 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 354.45 per share. | 24 May 2024 | 304 | 20,304 (0%) | 0% | 354.5 | 107,753 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 24 May 2024 | 10,294 | 10,293 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 582.41 per share. | 24 May 2024 | 10,294 | 62,568 (0%) | 0% | 582.4 | 5,995,301 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 90.51 per share. | 24 May 2024 | 10,294 | 72,862 (0%) | 0% | 90.5 | 931,710 | Common Stock |
| Mr. Bruce R. Chizen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 356 | 15,218 (0%) | 0% | 0 | Common Stock | |
| Ms. Jeannine P. Sargent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 356 | 2,053 (0%) | 0% | 0 | Common Stock | |
| Mr. John G. Schwarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 356 | 12,296 (0%) | 0% | 0 | Common Stock | |
| Ms. Janice Durbin Chaffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 356 | 14,678 (0%) | 0% | 0 | Common Stock | |
| Mr. Marc N. Casper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 356 | 2,092 (0%) | 0% | 0 | Common Stock | |
| Ms. Mercedes Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 356 | 2,053 (0%) | 0% | 0 | Common Stock | |
| Mr. Roy A. Vallee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 356 | 2,622 (0%) | 0% | 0 | Common Stock | |
| Mr. Luis A. Borgen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 356 | 1,342 (0%) | 0% | 0 | Common Stock | |
| Mr. Robert G. Painter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 356 | 1,450 (0%) | 0% | 0 | Common Stock | |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Sale of securities on an exchange or to another person at price $ 579.37 per share. | 03 Apr 2024 | 5,319 | 20,000 (0%) | 0% | 579.4 | 3,081,663 | Common Stock |
| Mr. Marc N. Casper | Director | Purchase of securities on an exchange or from another person at price $ 586.40 per share. | 25 Mar 2024 | 250 | 1,736 (0%) | 0% | 586.4 | 146,601 | Common Stock |
| Mr. Marc N. Casper | Director | Purchase of securities on an exchange or from another person at price $ 584.97 per share. | 25 Mar 2024 | 500 | 1,486 (0%) | 0% | 585.0 | 292,486 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 406 | 25,521 (0%) | 0% | 0 | Common Stock | |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 15 Mar 2024 | 406 | 1,217 | - | - | Restricted Stock Units | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 550.03 per share. | 15 Mar 2024 | 202 | 25,319 (0%) | 0% | 550.0 | 111,106 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 1,764 | 107,593 (0%) | 0% | 0 | Common Stock | |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 550.03 per share. | 15 Mar 2024 | 610 | 106,983 (0%) | 0% | 550.0 | 335,518 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | 15 Mar 2024 | 1,764 | 5,290 | - | - | Restricted Stock Units | ||
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 550.03 per share. | 15 Mar 2024 | 281 | 18,741 (0%) | 0% | 550.0 | 154,558 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | 15 Mar 2024 | 794 | 2,380 | - | - | Restricted Stock Units | ||
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 794 | 19,022 (0%) | 0% | 0 | Common Stock | |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 550.03 per share. | 15 Mar 2024 | 286 | 2,160 (0%) | 0% | 550.0 | 157,309 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | 15 Mar 2024 | 794 | 2,380 | - | - | Restricted Stock Units | ||
| Mr. Richard S. Mahoney | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 794 | 2,446 (0%) | 0% | 0 | Common Stock | |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 550.03 per share. | 15 Mar 2024 | 656 | 62,568 (0%) | 0% | 550.0 | 360,820 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 15 Mar 2024 | 1,323 | 3,967 | - | - | Restricted Stock Units | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 1,323 | 63,224 (0%) | 0% | 0 | Common Stock | |
| Ms. Shelagh Glaser | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 550.03 per share. | 15 Mar 2024 | 278 | 9,016 (0%) | 0% | 550.0 | 152,908 | Common Stock |
| Ms. Shelagh Glaser | CFO | 15 Mar 2024 | 794 | 2,380 | - | - | Restricted Stock Units | ||
| Ms. Shelagh Glaser | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 794 | 9,294 (0%) | 0% | 0 | Common Stock | |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Mar 2024 | 1,700 | 25,115 (0%) | 0% | 0 | Common Stock | |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Other type of transaction at price $ 282.63 per share. | 29 Feb 2024 | 35 | 26,815 (0%) | 0% | 282.6 | 9,892 | Common Stock |
| Dr. Aart J. De Geus, PhD | Director, EXECUTIVE CHAIR | Other type of transaction at price $ 261.55 per share. | 29 Feb 2024 | 38 | 105,829 (0%) | 0% | 261.6 | 9,939 | Common Stock |
| Mr. Sudhindra Kankanwadi | Chief Accounting Officer | Other type of transaction at price $ 282.63 per share. | 29 Feb 2024 | 35 | 18,228 (0%) | 0% | 282.6 | 9,892 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Other type of transaction at price $ 282.63 per share. | 29 Feb 2024 | 35 | 1,652 (0%) | 0% | 282.6 | 9,892 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Other type of transaction at price $ 261.55 per share. | 29 Feb 2024 | 38 | 61,901 (0%) | 0% | 261.6 | 9,939 | Common Stock |
| Ms. Shelagh Glaser | CFO | Other type of transaction at price $ 306.88 per share. | 29 Feb 2024 | 32 | 8,500 (0%) | 0% | 306.9 | 9,820 | Common Stock |
| Mr. Roy A. Vallee | Director | Sale of securities on an exchange or to another person at price $ 572.66 per share. | 27 Feb 2024 | 10,000 | 20,000 (0%) | 0% | 572.7 | 5,726,595 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 577.51 per share. | 23 Feb 2024 | 10,294 | 61,863 (0%) | 0% | 577.5 | 5,944,932 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 23 Feb 2024 | 1,219 | 3,656 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 354.45 per share. | 23 Feb 2024 | 1,219 | 27,999 (0%) | 0% | 354.5 | 432,075 | Common Stock |
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | 23 Feb 2024 | 10,294 | 20,587 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 90.51 per share. | 23 Feb 2024 | 10,294 | 72,157 (0%) | 0% | 90.5 | 931,710 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Sale of securities on an exchange or to another person at price $ 583.95 per share. | 23 Feb 2024 | 1,219 | 26,780 (0%) | 0% | 583.9 | 711,835 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 494.72 per share. | 03 Jan 2024 | 4,641 | 1,617 (0%) | 0% | 494.7 | 2,295,978 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | 03 Jan 2024 | 4,424 | 19,169 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. Richard S. Mahoney | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 319.20 per share. | 03 Jan 2024 | 4,424 | 10,682 (0%) | 0% | 319.2 | 1,412,141 | Common Stock |
| Mr. Richard S. Mahoney | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 494.68 per share. | 03 Jan 2024 | 4,424 | 6,258 (0%) | 0% | 494.7 | 2,188,454 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.88 per share. | 02 Jan 2024 | 1,572 | 28,352 (0%) | 0% | 135.9 | 213,603 | Common Stock |
| Ms. Mercedes Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.84 per share. | 02 Jan 2024 | 4,000 | 5,697 (0%) | 0% | 65.8 | 263,360 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Sale of securities on an exchange or to another person at price $ 506.18 per share. | 02 Jan 2024 | 1,572 | 26,780 (0%) | 0% | 506.2 | 795,715 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Sale of securities on an exchange or to another person at price $ 506.18 per share. | 02 Jan 2024 | 366 | 26,780 (0%) | 0% | 506.2 | 185,262 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 354.48 per share. | 02 Jan 2024 | 366 | 27,146 (0%) | 0% | 354.5 | 129,740 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 234.17 per share. | 02 Jan 2024 | 570 | 27,350 (0%) | 0% | 234.2 | 133,477 | Common Stock |
| Ms. Mercedes Johnson | Director | Sale of securities on an exchange or to another person at price $ 494.70 per share. | 02 Jan 2024 | 3,500 | 1,697 (0%) | 0% | 494.7 | 1,731,460 | Common Stock |
| Ms. Mercedes Johnson | Director | 02 Jan 2024 | 4,000 | 3,500 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 02 Jan 2024 | 366 | 2,929 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | Sale of securities on an exchange or to another person at price $ 506.18 per share. | 02 Jan 2024 | 570 | 26,780 (0%) | 0% | 506.2 | 288,523 | Common Stock |
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 02 Jan 2024 | 570 | 2,278 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mr. John F. Runkel, Jr | GC & Corporate Secretary | 02 Jan 2024 | 1,572 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Ms. Mercedes Johnson | Director | 02 Jan 2024 | 3,500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Ms. Mercedes Johnson | Director | Sale of securities on an exchange or to another person at price $ 506.15 per share. | 02 Jan 2024 | 4,000 | 1,697 (0%) | 0% | 506.2 | 2,024,617 | Common Stock |
| Ms. Mercedes Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.84 per share. | 02 Jan 2024 | 3,500 | 5,197 (0%) | 0% | 65.8 | 230,440 | Common Stock |